Search - tctmd.com

Displaying 521 - 540 of 1004

Sort: Relevancy | Date

Presentation TCT 2013

TCT-27. The Impact of Second Generation Drug-eluting Stent on Mid-term Clinical Outcome in Patients with Unprotected Left Main, Milan and New-Tokyo Registry

Presenter: Kensuke Takagi

October 29, 2013

Presentation TCT 2013

TCT-22. The STENTYS Self-Expanding Drug-Eluting Stent in Coronary Bifurcation Lesions at 6 Months Follow-up : Results from the OPEN II Trial

Presenter: Christoph Naber

October 29, 2013

Presentation TCT 2013

TCT-19. The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus

Presenter: Elvin Kedhi

October 29, 2013

Presentation TCT 2013

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

Presenter: Stephan Windecker

October 29, 2013

Presentation TCT 2013

Biodegradable-Polymer Drug-Eluting Stents versus Bare Metal Stents versus Durable-Polymer Drug-Eluting Stents : A Systematic Review and Bayesian Approach Network Meta-Analysis

Presenter: Si-Hyuck Kang

October 29, 2013

News Industry News

Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013

October 29, 2013

News Industry News

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

October 29, 2013

News Conference News TCT 2013

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

October 29, 2013

News Industry News

OrbusNeich’s COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months

October 29, 2013

News Industry News

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

October 29, 2013

News Industry News

MiStent SES Shown to be Unique in Clinical Setting

October 29, 2013

News Conference News TCT 2013

Memories of TCT from the Beginning: Martin B. Leon, MD

October 29, 2013

News Industry News

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

October 29, 2013

News Conference News TCT 2013

Bioresorbable Scaffold Stands Ground Next to Current DES

October 28, 2013

Presentation TCT 2013

Bare Metal and Drug-Eluting Stents: Indications, Outcomes, Complications

Presenter: Sahil Parikh

October 27, 2013

News Industry News

Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013

October 22, 2013

News Industry News

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

October 17, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

Jason Kahn

October 11, 2013

News Daily News

La Aspirina a Largo Plazo es tan Eficaz como la Terapia Doble en Pacientes SLF Sin Complicaciones

Jason Kahn

October 11, 2013

Advertisement

TCT-27. The Impact of Second Generation Drug-eluting Stent on Mid-term Clinical Outcome in Patients with Unprotected Left Main, Milan and New-Tokyo Registry

TCT-22. The STENTYS Self-Expanding Drug-Eluting Stent in Coronary Bifurcation Lesions at 6 Months Follow-up : Results from the OPEN II Trial

TCT-19. The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

Biodegradable-Polymer Drug-Eluting Stents versus Bare Metal Stents versus Durable-Polymer Drug-Eluting Stents : A Systematic Review and Bayesian Approach Network Meta-Analysis

Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013

STENTYS Sirolimus-Eluting Stent Demonstrates Faster Arterial Healing Than Conventional Drug-Eluting Stent

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

OrbusNeich’s COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

MiStent SES Shown to be Unique in Clinical Setting

Memories of TCT from the Beginning: Martin B. Leon, MD

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

Bioresorbable Scaffold Stands Ground Next to Current DES

Bare Metal and Drug-Eluting Stents: Indications, Outcomes, Complications

Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

La Aspirina a Largo Plazo es tan Eficaz como la Terapia Doble en Pacientes SLF Sin Complicaciones

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content